You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
One in four colorectal procedures result in readmission due to complications in the first 90 days.1 This represents a significant economic burden for hospitals. Our goal is to help improve outcomes, reduce costs and improve patient experience.
Shaping the Future of Surgery
Delivering Meaningful Innovation
The ECHELON CIRCULAR™ Powered Stapler is designed to reduce leaks without compromising perfusion—resulting in 61% fewer leaks at the staple line compared to the Medtronic DST Series™ EEA™ Stapler.*
Transforming Business Models
Single SSI can cost a hospital nearly $39,000.2 Triclosan sutures are proven to inhibit bacterial colonization of the suture. 3-5
Responding With a Caring Spirit
Quality is important — because at the end of every one of our devices is a patient. Hear from a Senior Principal Test Engineer about his colorectal surgery.
Over a Century of Meaningful Innovation
At Ethicon, weʼre focused on improving health outcomes for patients and helping solve the greatest health challenges… with only meaningful innovation. The kind that led to the creation of the first sutures, that helped revolutionize surgery with minimally invasive procedures, and that elevates standards of care around the world.
1887 — Sterile Sutures
Johnson & Johnson’s mass production of sterile sutures and other products ushered in the widespread practice of modern antiseptic surgery that dramatically raised survival rates.
1960 — SURGICEL® Original
SURGICEL® made history as the first oxidized regenerated cellulose hemostat and set a new standard for managing surgical bleeding.
1969 — PROLENE® Polypropylene Suture
The first synthetic sterile suture, PROLENE® Polypropylene Suture is used in cardiac bypass surgery for its strength, secure knotting and biocompatibility.
1978 — PROXIMATE® Disposable Skin Stapler
This game-changing skin stapler introduced disposable instruments to the OR. The success of disposable PROXIMATE opened the door to new innovations for open and minimally invasive procedures.
1979 — Coated VICRYL® (polyglactin 910) Suture
Used by surgeons around the world today for general surgery use, Coated VICRYL® (polyglactin 910) Suture balances the surgeon’s need for slide with knot security in achieving reliable approximation and closure.
1988 —Laparoscopic Cholecystectomy
First Laparoscopic Cholecystectomy and development of Minimally Invasive solutions
1993 — Ethicon Endo-Surgery
Founded in Ohio, Ethicon Endo-Surgery brought surgical technologies and solutions including staplers, energy devices and trocars.
1995 — Telesurgery
Our pioneering live telesurgery, Dr. J. Barry McKernan performed a laparoscopic cholecystectomy at the American College of Surgeons’ annual meeting introduced clinicians to the possibilities of distance learning.
1998 — DERMABOND® Topical Skin Adhesive
The first FDA-approved topical skin adhesive in the U.S., DERMABOND® Topical Skin Adhesive paved the way for replacing sutures with a new generation of skin closure solutions.18,19
1998 — HARMONIC® Shears
Our launch of the first 5mm HARMONIC® shears allowed surgeons for the first time to dissect, cut and coagulate with one ultrasonic energy device with minimal lateral thermal damage.
2000 — Fighting Obesity
Committed to shaping the future of surgery in the fight against obesity and metabolic diseases and helping to elevate the standard of care through research and evidence, best-in-class education and training, innovative products and expanding patient access to care.
2003 — PLUS Sutures
The first commercially available antibacterial suture, Coated VICRYL® Plus Antibacterial (polyglactin 910) Suture broke new ground in addressing a known risk factor for surgical-site infections (SSI), bacterial colonization of the suture.17
2011 — ECHELON FLEX™ Powered ENDOPATH® Stapler
This first powered endocutter with system-wide compression and stability helped to fuel the revolution to minimally invasive approaches. Less unwanted movement of the tip offered the potential for reduced trauma to vital structures, even in thick tissue and at awkward angles.
2015 — VERB Surgical Partnership
Verb Surgical, founded in 2015, is developing a digital surgery platform built with technology from Verily (formerly Google Life Sciences) and Ethicon Endo-Surgery, Inc. Verb’s platform will include robotics, visualization, advanced instrumentation, data analytics, and connectivity.
2016 — NEUWAVE Medical Acquisition
Ethicon acquires NeuWave Medical, Inc., a company that manufactures and markets minimally invasive soft-tissue microwave ablation systems. This acquisition is consistent with the strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology.
2017 — MEGADYNE Acquisition
The acquisition of Megadyne’s innovative portfolio of electrosurgical tools represents a major step forward in Ethicon’s goal to deliver the most comprehensive suite of intelligent energy solutions that enhance precision and efficiency in the operating room.
ASCRS Platinum Sponsor
The 2019 Annual Scientific Meeting is designed for colon and rectal surgeons as well as general surgeons and others involved in the treatment of diseases affecting the colon, rectum and anus.
We look forward to helping the Society enhance the care its members provide to patients.
Ethicon Plus Antibacterial Sutures: The only sutures with triclosan available worldwide
The use of triclosan-coated sutures for surgical site infection (SSI) prevention is now recommended by three globally recognized health authorities: Centers for Disease Control and Prevention (CDC)6‡, World Health Organization (WHO)7‡ and American College of Surgeons & Surgical Infection Society (ACS & SIS)8‡.
‡The CDC, WHO, and ACS/SIS guidelines on reducing the risk of surgical site infections are general to triclosan-coated sutures and are not specific to any one brand.
Ethicon is the market leader in Colorectal Surgery†
At Ethicon our goal is to provide products and support that help to improve patient outcomes. In pre-clinical testing, Ethicon products have been shown to outperform the competitor for these factors that are common considerations in colorectal procedures.
ECHELON CIRCULAR™ Powered Stapler
The ECHELON CIRCULAR Powered Stapler is designed to reduce leaks without compromising perfusion—resulting in 61% fewer leaks at the staple line compared to the Medtronic DST Series™ EEA™ Stapler.*
ECHELON FLEX™ GST System
The ECHELON FLEX GST System§ controls tissue movement to enable you to transect as you intend even on the most challenging tissue.
ENSEAL® X1 Large Jaw Tissue Sealer
Designed for use in open surgical procedures, ENSEAL X1 Large Jaw Tissue Sealer is an advanced bipolar device that provides better hemostasis, less thermal spread, and improved ergonomics compared to LigaSure Impact™.
STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device
STRATAFIX™ Symmetric is the only barbed suture that provides strong, secure closure appropriate for high-tension areas, such as fascia.9-14
Coated VICRYL® Plus Antibacterial (polyglactin 910) Suture
Coated VICRYL Plus Sutures offer benefits in a range of surgical applications, including smooth tissue passage, exceptional handling, and knot security.15
* Benchtop testing in porcine tissue ≤30mmHg (26mmHg average pressure experienced during intra-operative leak test), comparing Ethicon ECHELON CIRCULAR™ Powered Stapler CDH25P to Medtronic DST Series™ EEA™ Stapler EEA2535 (p<0.001) and preclinical perfusion model, in which perfusion was not significantly different between devices.
†DRG market data from July 2016 – June 2017, comparing market share in colorectal procedures.
§Benchtop testing in porcine colon compared the rate of staple line leak failure at ≤30mmHg, compared Ethicon CDH29P and CS40B/CR40B or PSEE45A/GST45B to Medtronic EEA2835/EGIAUSTND and EGIARADMT or EGIA45AMT, n=60 ea p<0.001. Leak rate at ≤30mmHg was selected based on a preclinical study that measured the intraluminal pressure associated with an intra-operative leak test by surgeons (n=31). Average selected pressure was 26 +/-1.8 mmHg.
1.Wick EC, Shore AD, Hirose K, et al. Readmission rates and cost following colorectal surgery. Dis Colon Rectum. 2011; 54(12):1475-1479.
2.Lissovoy, G. D., Fraeman, K., Hutchins, V., Murphy, D., Song, D., & Vaughn, B. B. (2009). Surgical site infection: Incidence and impact on hospital utilization and treatment costs. American Journal of Infection Control, 37(5), 387-397.
3.Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS Plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt). 2008;9(4):451-457.
4.Ming X, Rothenburger S, Nichols MM, Rothenburger S. In Vivo Antibacterial Efficacy of MONOCRYL Plus Antibacterial (Poliglecaprone 25 withTriclosan) Suture. Surg Infect (Larchmt). 2007; 8(2):1-5.
5.Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobialevaluation of coated Vicryl Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt). 2002;3 (suppl):S79-S87.
6. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection,2017. JAMA Surg. doi:10.1001/jamasurg.2017.0904.
7. WHO Global Guidelines for the Prevention of Surgical Site Infection, 2016.
8. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2016;224:59-74.
9. 100326296: Time Zero Tissue Holding - Competitive Claims Comparisons for STRATAFIX Knotless Tissue Control Devices vs Various Products. 2015.
10. Performance Testing of STRATAFIX SYMMETRIC PDS PLUS Size 0 & 1 Devices – Initiation Strength in Porcine Tissue. AST-2013-0603.
11. AST-2013-0056 Performance Testing of STRATAFIX Symmetric PDSSize2-0suture device for Tissue Holding Strength with Multiple Incision Defects to Measure Gapping.
12. Ethicon study PSE 09-0204, project number 11822. Exploratory histological and biomechanical evaluation of DOLFIN following closure of the ventral abdominal wall in a porcine model at 7±1 days. Approved on July 7, 2010.
13. Ethicon Performance Evaluation Memo AST-2012-0510. Performance Testing of STRATAFIX Symmetric Size 2-0 suture device for Tissue Holding Strength with an Incision Defect to Measure Gapping. Dated December 3, 2012.
14. STRATAFIX Symmetric PDS Plus Knotless Tissue Control Device. Instructions for Use. Ethicon, Inc.
15. Coated VICRYL Plus Antibacterial (polyglactin 910) Sutures Instructions for Use. Ethicon, Inc.